McDonald's Corporation

McDonald's defensive real estate and asset-light royalty model provides structural insulation against demand shifts. The company's diversified global footprint and digital loyalty ecosystem are seen as sufficient buffers to absorb any traffic losses from GLP-1 drug adoption, preserving elite cash-flow conversion over the long term.

Redburn Atlantic downgraded McDonald's to sell, warning that GLP-1 weight-loss drugs could eliminate approximately 28 million customer visits per year, translating to roughly $482 million in lost annual revenue — a structural demand threat that cannot be offset by promotional activity or menu changes alone.

Tigress Financial raised its price target to $390 and maintained a buy rating, reflecting confidence in McDonald's value strategy paying off and U.S. sales surging. The analyst consensus remains a Moderate Buy, with an average price target of $326–$338, implying meaningful upside from current depressed levels.

KeyBanc lowered its U.S. same-store sales estimate to just +0.5% versus a +1.1% consensus, citing a difficult April with no significant core business recovery. The firm warned that uncertainty around McDonald's turnaround strategy and tougher year-over-year comparisons could limit near-term share price gains.

McDonald's best-in-class 46% operating margin and asset-light franchise model structurally externalize cost pressures to franchisees, preserving corporate-level cash flows. Accelerated automation and digital loyalty monetization are identified as primary long-term drivers of margin preservation even amid inflationary headwinds.

A sharp divergence exists among analysts regarding franchisee solvency under value-pricing mandates, with persistent inflation squeezing unit-level economics. McDonald's stock has lagged the broader restaurant sector, reflecting investor concern that margin pressure at the franchisee level could eventually undermine the corporate model's stability.